In the News
In the News
Breakthrough Randomized Controlled Trial Demonstrating TWO2 Efficacy in Healing Diabetic Foot Ulcers unveiled at the American Diabetes Association 78th Scientific Sessions Conference
This breakthrough study unequivocally demonstrates at the highest scientific level the efficacy of Cyclical Pressure Topical Wound Oxygen Therapy in healing Diabetic Foot Ulcers” stated Dr. Robert Frykberg, the Chief Principle Investigator of the study.
Unprecedented Study Results Demonstrating Topical Wound Oxygen Effectiveness Presented at Major Wound Care Conferences
The study was a two-year retrospective review of 71 patients with a total of 115 wounds treated by a Veterans Affairs hospital in Chicago that prescribed cyclical pressurized TWO2 therapy for use at home.
AOTI Inc. Announces New York City Office Grand Opening
AOTI Inc. announced today that its fully owned USA-operating subsidiary, Advanced Oxygen Therapy Inc., has recently opened a New York City Office in Yonkers, New York to support the ever-increasing usage of its unique Topical Wound Oxygen (TWO2) homecare therapy. This new East Coast location has also been approved by the Accreditation Commission for Health Care (ACHC) under the company’s DMEPOS accreditation for Home/Durable Medical Equipment Services.
Topical Wound Oxygen (TWO2) Therapy Receives Strong Evidence Based Treatment Recommendations
OCEANSIDE, Calif., May 10, 2017 /PRNewswire/ -- AOTI Inc. announced today that its revolutionary patented Topical Wound Oxygen (TWO2) homecare therapy has received a Strong GRADE 1B Treatment recommendation in the European Wound Management Association (EWMA) guidance...
AOTI exceeds 1,000,000 home treatments with its revolutionary Topical Wound Oxygen Therapy
Oceanside, California USA, Apr 3 – AOTI Inc. announced today that over 1,000,000 home treatments have been provided with its revolutionary patented Topical Wound Oxygen (TWO2) therapy. “This is a momentous milestone for our company and a testament to the clinical...
AOTI Announces DMEPOS accreditation for Home & Durable Medical Equipment Services
Oceanside, California USA, Feb 17 – AOTI Inc. announced today that it’s fully owned USA operating subsidiary, Advanced Oxygen Therapy Inc., has been awarded DMEPOS accreditation for Home/Durable Medical Equipment Services by the Accreditation Commission for Health...
AOTI Announces Expansive Clinical Education Program for Desert Foot and Podiatric Residency Summits
Oceanside, California USA, Feb 14 – AOTI Inc. announced today that it will again be providing an expansive Clinical Education program at the Desert Foot conference, East and Midwest Podiatric Residency summits, which are the leading conferences focused on the Veterans...
24th Patent Granted for AOTI’s revolutionary Topical Wound Oxygen Therapy
Oceanside, California USA, Aug 16 – AOTI Inc. announced today the U.S. Patent and Trademark Office have granted its Patent Application No. 14/150,178 - CONTROLLER FOR AN EXTREMITY HYPERBARIC DEVICE that will now issue as U.S. Patent No. 9,421,147. This is the 24th...
AOTI treats 10,000th patient with its revolutionary Topical Wound Oxygen Therapy
Oceanside, California USA, Apr 16 – AOTI Inc. announced today the 10,000th patient has been treated with its revolutionary patented Topical Wound Oxygen Therapy. “This is a momentous milestone for our company and a testament to the clinical efficacy of TWO2 therapy,...